ORCL

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✗

Return

+4.21%

Status

scored

Oracle Underweight rating maintained with a 30-40% position trim executed at current $135 levels rather than waiting for a $142 bounce, per the binding 10/07 lesson that modest trims bleed alpha when all four technical signals align and the P/E has compressed to 12.34×. Full liquidation is rejected due to the $664B RPO/IG/cash structural floor anchoring $165-200B in contracted backlog, consistent with the 9/28 lesson; the $122 stop with <$130 confirmation and December $130/$110 put spread provide defined-risk protection.

Outcome

✓

Return

-5.48%

Status

scored

The analyst recommends a calibrated 10-15% trim of ORCL exposure at ~$143, rejecting both a full Sell and larger trim magnitudes as either too aggressive or historically alpha-leaking given intact structural floors. Residual position is defended by a $131 hard stop (below September swing low at $131.58) and hedged via a December $130/$110 put spread at 1-2% of residual notional.

Outcome

✓

Return

-0.84%

Status

scored

Analysts maintain HOLD on Oracle with a $130 hard stop (2.2 ATR below current price, below the $131.58 higher low) as three convergent signals support inaction: the 12.94x forward P/E has fully absorbed the bear case, the $664B RPO floor remains intact with $37.1B cash and $32B OCF, and the Q1 FY27 print (29.6% revenue growth, 55% EPS growth, 35.6% operating margin) was strong but not sufficient to disambiguate sustainable inflection from base-effect artifact. Post-Q2 FY27 contingencies are pre-defined: maintain Hold with $135 trailing stop if revenue exceeds $20B and FCF trajectory confirms, or reduce ~30% and set $124 stop if revenue disappoints below $19B.

Outcome

✓

Return

+1.61%

Status

scored

Maintain ORCL at Hold with pure passivity. The four prior Underweight decisions leaked ~7.3% cumulative alpha, making directional tilts empirically contraindicated on this ticker. Scale-in only on confirmed breakout above $145.17 with volume, MACD bullish cross, and RSI > 55, at 50-75% of normal increment. Stop at $138 exactly; reject the Conservative's $140 suggestion as operationally loosening (ATR $6.69 makes $140 a noise stop). Target $160-162; mandatory reassessment at December FY26 Q2 earnings.

Outcome

–

Return

+0.13%

Status

scored

The Underweight rating compresses trim magnitude to ~10% of ORCL exposure (down from 15-20% in the prior decision that leaked +2.3% alpha), staged in thirds at ~$142, $146-150, and below $130. The split-entry framework and 6-7 month 10-12% OTM put spreads (1.5-2% of notional) capture the December RPO binary event without over-trimming at the upper band, given the 12.94× forward P/E already prices in most of the bear case.

Outcome

✗

Return

+3.06%

Status

scored

Oracle receives UNDERWEIGHT rating with a 15-20% position trim staged over 8-12 sessions, reducing to 80-85% benchmark weight via VWAP/limit orders at $137-142; a December $130/$110 put spread (2-3% of residual notional) provides defined-risk downside protection while honoring the intact structural floor anchored by $664B RPO and $36.4B cash. Entry triggers include FCF inflection, macro turn, or technical reclaim above $155 on volume, with mandatory re-evaluation at December FY27 Q2 earnings.

Outcome

✗

Return

+0.56%

Status

scored

Trim ORCL by 30-40% via limit orders at $142-145 (falling back to market trim if no bounce materializes), maintaining a residual 1.5-2% position with a hard stop at $128 closing basis. Reject the trader's $148/$152 stock short as mechanically broken (0.57x ATR stop will be clipped by noise in a beta-1.73 name), instead expressing bearish view via defined-risk December $130/$110 put spreads at 2-3% of residual notional. Reassess at Q2 FY26 earnings for capex trajectory, RPO conversion, and Wisconsin timeline.

Outcome

✓

Return

-0.36%

Status

scored

Maintain ORCL at current levels around $138 with a defined-risk put-spread hedge rather than trimming at the upper Underweight band. The $664B RPO contractual floor remains intact, and the 9/28 lesson demonstrates that equity trims at upper Underweight bands leak alpha when structural floors hold. Position sized at 3-4% of portfolio given beta 1.73 and ATR $7.28.

Outcome

✗

Return

+3.91%

Status

scored

Trim 40-50% of ORCL exposure at market (~$132) as the Research Manager's Underweight directive supersedes the trader's rejected SELL proposal; the trader's $142 entry with $147.50 stop is mechanically broken at only 0.08x ATR (~7) and will be clipped by noise 80% of the time in this beta-1.73 name. For residual position, defend with hard stop at $128 closing basis and express tactical bearish view via failed retests of $142-147 resistance with 1.0 ATR stops (~$135) or defined-risk December $130/$110 put spreads at 2-3% of notional.

Outcome

✓

Return

-3.28%

Status

scored

Trim 40-50% of existing ORCL exposure at the upper end of the Underweight band, maintaining a residual position of ~1.5-2% of book with a hard stop at $128 closing basis; no new long initiation. Execute via limit orders at $137-140 with a 5-day time stop, hedging with December $130 puts at 2-3% of residual position notional, and reassess at December 2025 Q2 FY27 earnings.

Outcome

✓

Return

-1.75%

Status

scored

Trim 30-40% of ORCL via limit orders at $142 with a 5-day time stop (or market if unfilled); retain 60-70% residual with hard stop at $114.50. Underweight rather than Sell because the $664B RPO floor and ~$165-200B residual contracted backlog provide bounded downside support worth preserving, while the confirmed downtrend (MACD negative, price 15% below declining 200-SMA, ATR $7.34, beta 1.73) warrants reduction versus passive Hold.

Outcome

✗

Return

-3.47%

Status

scored

All three risk analysts converge on HOLD for Oracle at ~$144, with fundamentals (Q1 FY27 +30% YoY revenue, $664B contracted RPO, 41.2% ROE) too robust for Sell, but negative TTM FCF (-$45.9B) and bearish technical setup (MACD cross, price 12% below 200 SMA at $164.60) too hostile for Buy initiation. Execute the trader's framework: $164.60 reclaim on >20M volume triggers add toward Overweight; $137.71 close triggers 10-15% trim toward Underweight.

Outcome

✓

Return

-3.11%

Status

scored

ORCL rating is HOLD at $149, with the decision explicitly proscribing both initiation and trimming based on the binding 9/21 lesson that zero trim is alpha-optimal when the $664B RPO floor is confirmed and price presses the lower bound of consolidation without breaking it. The $115 stop represents ~23% downside (using ATR of $7.21), and the framework requires waiting for either a flush to $135-$140 with stable RPO commentary (light accumulation trigger) or a confirmed close above $165 on volume (200-SMA reclaim for full position addition).

Outcome

–

Return

+0.43%

Status

scored

Trim 10-20% of ORCL exposure at the $148 level to monetize the intact $664B RPO floor while reducing exposure to broken technicals and deeply negative FCF; maintain residual core position (~80-90%) with closing-basis stop at $141, and hedge via March 2026 $130 puts at 2-3% of residual position value. The Underweight rating is supported by the contractually-anchored RPO floor (ruling out Sell), broken technicals on a high-beta name (ruling out Hold), and the empirical record showing Underweight calls on this ticker produced +0.75% alpha versus -1.9% alpha from the 9/17 Hold.

Outcome

–

Return

+0.64%

Status

scored

Trim 35-45% of ORCL at $147 given decisively negative technicals (failed rally, lower highs, MACD rolling negative) while maintaining a 1.5-2.0% residual core position with a $141 closing-basis stop—this calibrates between pure passivity and full exit given the intact $664B RPO floor and IG credit profile.

Outcome

✓

Return

-1.98%

Status

scored

Maintain ORCL at current exposure as the $664B contractually-anchored RPO floor prevents aggressive trimming while the intact technical downtrend, persistent negative FCF, and asymmetric downside risk into the next print prevent accumulation. The risk/reward is balanced at approximately 1:1.5-2 on the 6-12 month tactical horizon, with the next 2-3 quarterly prints and Fed cycle providing resolution catalysts.

Outcome

✗

Return

+5.19%

Status

scored

Oracle faces a confirmed failed breakout with price 14% below the 200 SMA ($165.98) and MACD histogram widening at -1.36; trim 25-30% of existing ORCL exposure at current levels while maintaining a hard stop at $134.50 for the residual core position. Despite the Underweight thesis, the $664B contracted backlog from credit-worthy counterparties and 121% YoY IaaS growth provide genuine RPO floor support that prevents a full Sell rating. Re-engagement is tiered: first add at close >$155 with positive MACD histogram, full re-engagement requires 200 SMA reclaim on >25M volume plus Q2 FY27 capex normalization.

Outcome

✗

Return

+2.00%

Status

scored

Maintain a measured Underweight on ORCL with a 25-30% trim of the sub-2% position ahead of the FOMC, leaving a residual 1.4-1.5% of book defended by a hard stop at $114; replace existing $130-135 puts with $120 strike 3-month protection to better match technical support and current IV regime. Rejection of any adds-on-flush tactic pending confirmed MACD turn and 10 EMA reclaim on >25M volume, with tiered re-engagement starting at 75% size only on close above $155 with MACD histogram expansion plus volume confirmation.

Outcome

✓

Return

-3.07%

Status

scored

Trim 40-50% of ORCL exposure ahead of the September 16 FOMC due to high beta (1.73), maximum Fed hawkishness odds, and accelerating capex ($28.5B Q1 FY27) against negative FCF (-$45.85B TTM) with no near-term catalyst resolution. Redeploy proceeds into AI-application software, defensive sectors, or short-duration fixed income rather than cash.

Outcome

✓

Return

-3.65%

Status

scored

Oracle warrants an Underweight rating with a 20-30% trim into the $162 resistance zone rather than selling into short-term noise at the 10 EMA. Retain a 2-3% core position with a hard stop at $140.63 (50 SMA closing basis), pending three explicit re-entry catalysts: 200 SMA reclaim above $166.82 with volume >25M and MACD expansion, two consecutive quarters of FCF inflection (OCF > Capex), and explicit OpenAI concentration disclosure. The failed breakout post-print with 50.9M share distribution on a 7% reversal is the dispositive signal warranting measured reduction rather than passive maintenance.

Outcome

✗

Return

-1.74%

Status

scored

Initiate ORCL at Overweight with 35-40% of intended position in the $148-153 zone, using a hard stop at $140 (closing basis); trim 25% on confirmed close below $148 with volume >20M, add only on confirmed close above $158 with volume >25M and MACD histogram expansion, and take profits at $167-172 and $185-195 while letting 50% run toward $220. The $185 price target reflects a 12-18 month structural thesis on 20x forward EPS of $10.97, with 3-6 month tactical horizon to first trim targets.

Outcome

✗

Return

-5.38%

Status

scored

Maintain ORCL at sub-2% of book with a hard stop at $139.72 and no new capital deployment ahead of Thursday's Q1 FY27 earnings catalyst; historical pre-catalyst Underweights at resistance have leaked alpha on this ticker, while disciplined Hold positioning with sub-2% sizing captured +2.7% to +4.6% alpha when catalysts resolved favorably. Trim 25% on confirmed close below $148 with volume >20M; full exit on close below $139.72 on volume.

Outcome

✓

Return

-0.55%

Status

scored

Maintain ORCL at sub-2% of book with a single hard stop at $115 (closing basis) and no new capital deployment ahead of Thursday's Q1 FY27 earnings catalyst. The empirical track record on this ticker is dispositive: pre-catalyst Underweights at resistance have consistently leaked alpha, while disciplined Hold with sub-2% sizing captured +2.7% to +4.6% alpha when catalysts resolved favorably. This is a "wait for clarity" setup with trim trigger at 25% on confirmed close below $140 with volume.

Outcome

✓

Return

+2.36%

Status

scored

Maintain ORCL at sub-2% of book with a hard stop at $139.72 (closing basis) and no new capital deployment ahead of the September 10 binary catalyst. The empirical track record shows pre-catalyst Underweights at resistance have consistently leaked alpha while disciplined Hold with sub-2% sizing captured meaningful upside when catalysts resolved favorably. The risk/reward at $158.78 is approximately 1:1, supporting patience over directional commitment.

Outcome

✗

Return

+3.08%

Status

scored

Trim ORCL by 25-30% targeting ~50% of current allocation, executing into any rally retesting the $156-160 resistance zone; hard stop at $147.70 closing basis. The decision reflects a calibrated Underweight synthesis: acknowledging technical/capex/valuation headwinds while preserving RPO-anchored upside participation, with Q1 FY27 earnings as the mandatory reassessment point.

Outcome

✗

Return

+5.69%

Status

scored

Hold ORCL at sub-2% of book with a single hard stop at $115 (July panic low) ahead of the Sep 8 Q1 FY27 binary catalyst. The 9/01 template (sub-2% sizing + hard stop + committed Hold) just produced +2.7% alpha and is the binding operational framework—pre-catalyst trims have consistently leaked alpha on this ticker (8/24 +1.3%, 8/25 +2.8%, 8/28 -5.3%, 8/31 -4.5%). No new capital deployment before earnings; trim 25% only on confirmed close below $140 with volume, with a calibrated three-tier post-earnings playbook (add 15-25% on clean print, 10% on partial, trim 25-40% on soft print, exit on adverse disclosure).

Outcome

✗

Return

+3.13%

Status

scored

Maintain ORCL at sub-2% of book with a single hard stop at $115 (closing basis) and a 25% trim trigger on confirmed close below $140 with volume. No new capital deployment until Q1 FY27 earnings resolve the FCF inflection question. The synthesis balances the aggressive analyst's structurally compelling but operationally incorrect Buy thesis against the conservative analyst's valid structural concerns that overreach on timing; the neutral analyst's 2.5:1 to 3:1 reward-to-risk calculation is the honest math.

Outcome

✗

Return

-5.23%

Status

scored

Maintain current ORCL exposure with a widened hard stop at $134, no-adds discipline until FY27 Q1 earnings confirm FCF inflection, and position size capped at 3% of book with 25% trim on approach to $155-156. The empirical track record on this ticker and the structural risk asymmetry (bull needs 5 concurrent positives, bear needs only 1) both argue for committed Hold with single stop, not elaborate machinery.

Outcome

✓

Return

-1.15%

Status

scored

Hold ORCL at current levels as empirical evidence (8/26 Hold generated +1.4% alpha, 8/20 Hold +2.7% alpha) shows patient Hold outperforms pre-trims on this ticker. Aggressive analyst's "add at $141" conflicts with trader's $141.40 stop—same level, not asymmetry. Maintain core exposure without adding or reducing; set single hard stop at $141.40 (50 SMA) with two conditional add triggers: primary breakout above $156.22 on ≥25M volume or secondary pullback to $140-141 with 50 SMA holding on declining volume. Mandatory reassessment at Q1 FY27 print.

Outcome

✓

Return

-0.72%

Status

scored

Oracle earns an Underweight rating at 70% of benchmark weight with a $135 closing stop, reflecting structural concerns (700bps gross margin compression, $156B debt, negative tangible book) that warrant below-index exposure, while preserving residual RPO-anchored floor thesis; execution is staged across 5-7 sessions beginning post-Jackson Hole with mandatory reassessment after Q1 FY27 print (mid-September 2026). The most recent 8/26 Hold template (+1.4% alpha) is the binding constraint—directional reduction without surrendering magnitude asymmetry.

Outcome

✓

Return

+2.06%

Status

scored

Maintain ORCL at Hold with a $130 single hard stop and no new capital deployment until after NVDA earnings tomorrow (Aug 27) and ORCL Q1 FY27 in mid-September. The 8/25 Underweight call (+2.8% alpha against) is dispositive evidence that trim-into-strength and load-into-weakness strategies underperform the Hold-with-single-stop template on this name; the binding lesson is that patience through the binary catalyst cluster preserves the magnitude asymmetry the fundamental thesis claims while avoiding catastrophic losses on a NVDA miss given ORCL's 1.72 beta.

Outcome

✗

Return

+2.84%

Status

scored

Trim 25-30% of ORCL exposure over 2-3 sessions using limit orders at $145-$148, completing reduction if price sustains into $155-$161 zone. Maintain a residual 1.0%-1.5% of NAV with a hard stop at $132, sized to capture potential squeeze upside if backlog conversion inflects while limiting downside from this leveraged, FCF-negative, technically-broken setup. No hedging on the residual given structurally alpha-negative premium costs on a beta 1.72 name with elevated implied vol.

Outcome

✗

Return

+1.62%

Status

scored

Trim 70% of ORCL exposure before the NVIDIA earnings on August 26 and Jackson Hole on August 28, retaining 30% of the original position as a small catalyst sleeve. Reassess after the catalyst window using the $156.22 reclaim with expanding volume and renewed momentum as the re-entry signal, while monitoring $121.30 for review and $114.99 for structural failure.

Outcome

✓

Return

-2.74%

Status

scored

Maintain ORCL at 50% of normal position size with a single hard stop at $140.79, mandatory collar hedging (sell $150 call / buy $130 put for ~1.5-2% premium), and a mid-September Q1 FY27 print reassessment. The probability-weighted expected return of -2.2% supports a Hold; aggressive sizing up is mathematically wrong while further derisking lacks probability support. The binding lesson from 8/19-8/20 is that simpler posture with mandatory collar hedge outperforms elaborate multi-tier frameworks on this name.

Outcome

✓

Return

+3.10%

Status

scored

Maintain Hold on ORCL with mandatory collar hedge (sell $150 call/buy $130 put, ~1.5-2% premium) into the mid-September Q1 FY27 print. Keep $114 hard stop and simplified entry trigger (confirmed close above $146 on volume ≥20M with MACD bullish cross), rejecting the elaborate tiered deployment framework as adding friction without payoff on this anomalously cheap setup (13x forward P/E, $638B contracted backlog, 53% ROE).

Outcome

✓

Return

-1.21%

Status

scored

Maintain ORCL at current weight with mandatory collar hedging into the September Q1 FY27 print, as the setup presents balanced probability asymmetry (bear needs one failure, bull needs multiple wins) but magnitude asymmetry favors the bull (13.2x forward P/E on $638B contracted backlog is anomalously cheap). Deploy tiered entries on technical confirmations with a $137 hard stop, avoiding the elaborate trim machinery criticized in prior lessons.

Outcome

–

Return

+0.71%

Status

scored

Portfolio Manager maintains Underweight rating on ORCL, recommending a 25-30% trim of existing exposure via dual triggers while retaining a smaller residual of 25-30% of benchmark weight (down from the 8/17 decision's 40% cap), citing repeated failure of the "hold through mixed conviction" pattern that generated -3.5% alpha (8/13) and -2.1% alpha (8/14), and applying a tighter $128 hard stop with mandatory collar hedging into the Q1 FY27 print.

Outcome

✓

Return

-2.63%

Status

scored

Trim ORCL by 50% using dual triggers: 40% on a confirmed close at $150–152 (50 SMA rejection), and an additional 10–15% if price breaks below $142 before tagging $150, with a hard stop at $135 on the residual and a soft trim trigger at $140. Cap residual at 40% of benchmark weight and consider a put hedge (2–4% of position) into the September Q2 FY27 print to manage binary catalyst risk.

Outcome

✓

Return

-2.57%

Status

scored

Maintain ORCL with a measured 15-20% trim and hard stop at $144.50, with mandatory collar hedging (sell $155 call/buy $140 put) ahead of the Q1 FY27 binary catalyst. The decision balances bearish technicals and credit risk against strong fundamentals (17.4% revenue growth, 570bps margin expansion, 0.85 PEG, 13.8x forward P/E), defaulting to Hold given the 3-for-3 pattern of Underweight calls generating negative alpha. Re-evaluate at Q1 FY27 print in mid-September 2026.

Outcome

✓

Return

-3.65%

Status

scored

Maintain ORCL at Hold with a hard stop at $144.50, adding only on confirmed breakout above $175.73 with 1.5x volume (max 25% of current position). Trim triggers include 50 SMA failure at $153.66, OCI deceleration below 40% YoY, AI customer capex cuts, or HY OAS widening 100bps+, with optional collar hedging into Q1 FY27 print.

Outcome

✗

Return

+1.92%

Status

scored

Oracle warrants a measured reduction with a 15-20% trim targeting the upper end near the $155.41 50 SMA resistance and lower end on momentum deterioration, leaving 80-85% of position intact with a $143.20 hard stop. The decision reflects mixed conviction: hard technical signals (50 SMA rejection, plateauing capex) and balance sheet stress (negative FCF -$23.7B, D/E 388%) argue for trimming, while strong fundamentals (Forward PE 14.06, 53.4% ROE, +20.6% revenue growth) and prior failed Underweight calls argue against over-aggressive de-risking. Re-entry requires two-of-three confirmations (structural reclaim above $165, post-catalyst basing at $135-140, or fundamental inflection in FCF/capex/debt), and Tranche 3 should execute pre-print to reduce binary exposure ahead of the mid-September Q1 FY27 catalyst.

Outcome

✗

Return

+5.36%

Status

scored

ORCL is rated Underweight with a $120 price target and $114 stop loss, recommending a trim to 35-50% of neutral allocation while avoiding new longs above $145; the position reflects unsustainable FCF (-$23.7B with capex at 83% of revenue), distressed CDS spreads, broken technicals with price 15% below the declining 200 SMA at $177.60, and capital structure fragility (D/E 388%, $40B net debt issuance). Re-entry requires 50 SMA reclaim at $157 with volume plus either positive TTM FCF or successful debt issuance at reasonable rates (two of three conditions), with the Aug 12 CPI print serving as a tactical checkpoint.

Outcome

✓

Return

-3.69%

Status

scored

Trim 25-30% of ORCL into the $151 bounce while maintaining 70-75% core exposure, with a hard stop at $128 on the remainder—below the Bollinger middle band at $130.45 and providing 1.7 ATR cushion. Rotate trimmed capital into short-duration Treasuries or low-beta quality names; re-entry requires dual confirmation of equity base formation above $114 AND CDS spread compression from GFC-comparable levels. Jackson Hole and next earnings serve as hard catalyst checkpoints for the 3-6 month time horizon.

Outcome

✗

Return

+2.74%

Status

scored

Oracle warrants an Underweight call with a 20-25% position trim targeting 65-75% of benchmark weight, driven by operational strength (FY26 revenue +17.4%, record 33.3% operating margin) that cannot offset capital structure fragility (FCF -$23.7B, D/E 388%, tangible book -$19.8B). The recommended hedge uses ITM puts at $140-$145 strikes with a short at $115 to create a $25-wide protection window at 1.5-2.5% premium cost, paired with a two-tier stop discipline ($129 tactical, $114.99 thesis-invalidation) and re-entry requiring two of three criteria including FCF normalization and successful debt issuance.